UBE3A isoform 2 is exclusively localized to the cytoplasm (74, 75), and recent work examining Angelman syndrome–associated missense mutations suggests that cytoplasmic localization of UBE3A at the expense of its nuclear targeting is a predictor of pathogenicity, irrespective of catalytic function (73). This evidence concerns the gene UBE3A and Angelman syndrome.